Skip to content

Seaport Therapeutics SPTX Other accrued liabilities

Other accrued liabilities at other companies

MYR Group logo
MYR GroupMYRG
$133.99M+19.9%
Kulicke & Soffa Industries logo
Kulicke & Soffa IndustriesKLIC
$4.72M
Archer Daniels Midland logo
Archer Daniels MidlandADM
$4.05B+15.4%
Portland General Electric logo
Portland General ElectricPOR
$449M+2.7%
Arcosa logo
ArcosaACA
$27.3M-61.7%
Valaris logo
ValarisVAL
$379.2M+3.8%

Other financials

Income statement

See full
Operating income-$27.5M-70.2%
Net income-$25.4M-93.6%
EPS (diluted)-$10.34-83.0%

Balance sheet

See full
Cash & equivalents$52.9M
Total debt$5.3M
Total equity-$115.6M-220%
Total assets$227.7M

Cash flow

See full
Operating cash flow-$20.2M+0.2%
CapEx--100%
Free cash flow-$20.2M+0.4%

Valuation

See full
Market cap$972.65M
Enterprise value$925.08M

Returns & leverage

See full
Debt / equity-0×
Current ratio13.2×

Where this comes from

Reported directly by Seaport Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:OtherLiabilitiesCurrent.

The official record: Seaport Therapeutics ’s 10-Q, filed June 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Seaport Therapeutics 's other accrued liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Seaport Therapeutics 's other accrued liabilities?
Seaport Therapeutics (SPTX) reported other accrued liabilities of $11K in Q1 2026.
What does other accrued liabilities mean?
This captures miscellaneous short-term obligations that do not fit into standard categories like accounts payable or accrued compensation. It often includes items such as customer deposits, short-term tax provisions, or other minor contractual liabilities. It provides insight into the breadth of the company's short-term financial commitments.